Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0R2QG
|
|||
| Former ID |
DIB016666
|
|||
| Drug Name |
TMI-358
|
|||
| Synonyms |
Terbinafine hydrochloride + polyethylene glycol; Onychomycosis micro-implant, Talima Therapeutics
Click to Show/Hide
|
|||
| Indication | Onychomycosis [ICD-11: EE12.1] | Phase 2 | [1] | |
| Company |
Talima Therapeutics Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01093118) A Study to Evaluate TMI-358 in the Treatment of Distal Subungual Onychomycosis. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.